Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

1.

Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens.

Trieu A, Kayala MA, Burk C, Molina DM, Freilich DA, Richie TL, Baldi P, Felgner PL, Doolan DL.

Mol Cell Proteomics. 2011 Sep;10(9):M111.007948. doi: 10.1074/mcp.M111.007948. Epub 2011 May 31.

PMID:
21628511
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Profiling humoral immune responses to P. falciparum infection with protein microarrays.

Doolan DL, Mu Y, Unal B, Sundaresh S, Hirst S, Valdez C, Randall A, Molina D, Liang X, Freilich DA, Oloo JA, Blair PL, Aguiar JC, Baldi P, Davies DH, Felgner PL.

Proteomics. 2008 Nov;8(22):4680-94. doi: 10.1002/pmic.200800194.

PMID:
18937256
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.

Cummings JF, Spring MD, Schwenk RJ, Ockenhouse CF, Kester KE, Polhemus ME, Walsh DS, Yoon IK, Prosperi C, Juompan LY, Lanar DE, Krzych U, Hall BT, Ware LA, Stewart VA, Williams J, Dowler M, Nielsen RK, Hillier CJ, Giersing BK, Dubovsky F, Malkin E, Tucker K, Dubois MC, Cohen JD, Ballou WR, Heppner DG Jr.

Vaccine. 2010 Jul 12;28(31):5135-44. doi: 10.1016/j.vaccine.2009.08.046. Epub 2009 Sep 6.

PMID:
19737527
[PubMed - indexed for MEDLINE]
5.

Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.

Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA.

Infect Immun. 2006 Aug;74(8):4573-80.

PMID:
16861644
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.

Chuang I, Sedegah M, Cicatelli S, Spring M, Polhemus M, Tamminga C, Patterson N, Guerrero M, Bennett JW, McGrath S, Ganeshan H, Belmonte M, Farooq F, Abot E, Banania JG, Huang J, Newcomer R, Rein L, Litilit D, Richie NO, Wood C, Murphy J, Sauerwein R, Hermsen CC, McCoy AJ, Kamau E, Cummings J, Komisar J, Sutamihardja A, Shi M, Epstein JE, Maiolatesi S, Tosh D, Limbach K, Angov E, Bergmann-Leitner E, Bruder JT, Doolan DL, King CR, Carucci D, Dutta S, Soisson L, Diggs C, Hollingdale MR, Ockenhouse CF, Richie TL.

PLoS One. 2013;8(2):e55571. doi: 10.1371/journal.pone.0055571. Epub 2013 Feb 14.

PMID:
23457473
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.

Bijker EM, Bastiaens GJ, Teirlinck AC, van Gemert GJ, Graumans W, van de Vegte-Bolmer M, Siebelink-Stoter R, Arens T, Teelen K, Nahrendorf W, Remarque EJ, Roeffen W, Jansens A, Zimmerman D, Vos M, van Schaijk BC, Wiersma J, van der Ven AJ, de Mast Q, van Lieshout L, Verweij JJ, Hermsen CC, Scholzen A, Sauerwein RW.

Proc Natl Acad Sci U S A. 2013 May 7;110(19):7862-7. doi: 10.1073/pnas.1220360110. Epub 2013 Apr 18.

PMID:
23599283
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

Tine JA, Lanar DE, Smith DM, Wellde BT, Schultheiss P, Ware LA, Kauffman EB, Wirtz RA, De Taisne C, Hui GS, Chang SP, Church P, Hollingdale MR, Kaslow DC, Hoffman S, Guito KP, Ballou WR, Sadoff JC, Paoletti E.

Infect Immun. 1996 Sep;64(9):3833-44.

PMID:
8751936
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3.

Daubersies P, Thomas AW, Millet P, Brahimi K, Langermans JA, Ollomo B, BenMohamed L, Slierendregt B, Eling W, Van Belkum A, Dubreuil G, Meis JF, Guérin-Marchand C, Cayphas S, Cohen J, Gras-Masse H, Druilhe P.

Nat Med. 2000 Nov;6(11):1258-63. Erratum in: Nat Med 2000 Dec;6(12):1412. Mohamed LB [corrected to BenMohamed L].

PMID:
11062538
[PubMed - indexed for MEDLINE]
10.

Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection.

Polley SD, Tetteh KK, Lloyd JM, Akpogheneta OJ, Greenwood BM, Bojang KA, Conway DJ.

J Infect Dis. 2007 Jan 15;195(2):279-87. Epub 2006 Dec 13.

PMID:
17191173
[PubMed - indexed for MEDLINE]
Free Article
11.

The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.

de Silva HD, Saleh S, Kovacevic S, Wang L, Black CG, Plebanski M, Coppel RL.

Malar J. 2011 Sep 16;10:266. doi: 10.1186/1475-2875-10-266.

PMID:
21920045
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.

Douglas AD, Williams AR, Illingworth JJ, Kamuyu G, Biswas S, Goodman AL, Wyllie DH, Crosnier C, Miura K, Wright GJ, Long CA, Osier FH, Marsh K, Turner AV, Hill AV, Draper SJ.

Nat Commun. 2011 Dec 20;2:601. doi: 10.1038/ncomms1615. Erratum in: Nat Commun. 2013;4. doi:10.1038/ncomms3355.

PMID:
22186897
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines.

White MT, Griffin JT, Riley EM, Drakeley CJ, Moorman AM, Sumba PO, Kazura JW, Ghani AC, John CC.

Proc Biol Sci. 2011 May 7;278(1710):1298-305. doi: 10.1098/rspb.2010.1697. Epub 2010 Oct 13.

PMID:
20943696
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.

Carapau D, Mitchell R, Nacer A, Shaw A, Othoro C, Frevert U, Nardin E.

Infect Immun. 2013 Dec;81(12):4350-62. doi: 10.1128/IAI.00263-13. Epub 2013 Sep 16.

PMID:
24042110
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.

Nguyen TV, Sacci JB Jr, de la Vega P, John CC, James AA, Kang AS.

Malar J. 2009 Oct 23;8:235. doi: 10.1186/1475-2875-8-235.

PMID:
19852802
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants.

Bustamante LY, Bartholdson SJ, Crosnier C, Campos MG, Wanaguru M, Nguon C, Kwiatkowski DP, Wright GJ, Rayner JC.

Vaccine. 2013 Jan 2;31(2):373-9. doi: 10.1016/j.vaccine.2012.10.106. Epub 2012 Nov 10.

PMID:
23146673
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.

Stowers AW, Kennedy MC, Keegan BP, Saul A, Long CA, Miller LH.

Infect Immun. 2002 Dec;70(12):6961-7.

PMID:
12438375
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36.

Horii T, Shirai H, Jie L, Ishii KJ, Palacpac NQ, Tougan T, Hato M, Ohta N, Bobogare A, Arakaki N, Matsumoto Y, Namazue J, Ishikawa T, Ueda S, Takahashi M.

Parasitol Int. 2010 Sep;59(3):380-6. doi: 10.1016/j.parint.2010.05.002. Epub 2010 May 20.

PMID:
20493274
[PubMed - indexed for MEDLINE]
19.

Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.

Arakawa T, Komesu A, Otsuki H, Sattabongkot J, Udomsangpetch R, Matsumoto Y, Tsuji N, Wu Y, Torii M, Tsuboi T.

Infect Immun. 2005 Nov;73(11):7375-80.

PMID:
16239536
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Profiling the antibody immune response against blood stage malaria vaccine candidates.

Gray JC, Corran PH, Mangia E, Gaunt MW, Li Q, Tetteh KK, Polley SD, Conway DJ, Holder AA, Bacarese-Hamilton T, Riley EM, Crisanti A.

Clin Chem. 2007 Jul;53(7):1244-53. Epub 2007 May 17.

PMID:
17510307
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk